相关实验视频
Updated: Jun 19, 2025
05:25
Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
684
解锁心脏保护:iPSC外体将Nec-1传递到PARP1/AIFM1轴的目标,缓解高频氧化应激和线粒体功能障碍
Xiaobing Lv1,2, Boqin Liu3, Xiaoting Su4
1Department of Cardiology, Jinan Central Hospital, Shandong University, No.105 Jiefang Road, Lixia District, Jinan, Shandong Province, 250013, P. R. China.
Journal of translational medicine
|July 26, 2024
概括
诱导的多能干细胞衍生外体载有Necrostatin-1 (Nec-1) 有效地通过减少氧化应激和通过PARP1/AIFM1通路改善线粒体功能来治疗心力衰竭 (HF).
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 再生医学是一种再生医学.
背景情况:
- 心力衰竭 (HF) 标志着氧化应激和线粒体功能障碍.
- 尼克罗斯塔丁-1 (Nec-1) 显示出用于HF治疗的潜力.
- 来自诱导多能干细胞 (iPSCs) 的外体提供了一个新的药物递送系统.
研究的目的:
- 在HF的老鼠模型中,通过iPSC衍生的外体传递Nec-1的治疗疗效的研究.
- 探索涉及PARP1/AIFM1轴的作用机制.
- 评估对氧化应激和线粒体功能的影响.
主要方法:
- 建立了心力衰竭的老鼠模型.
- 从iPSCs中分离和特征Nec-1-载荷的外体 (Nec-1-Exos).
- 给HF大鼠服用Nec-1-Exos并评估心脏功能,血液动力学和心肌组织学.
- 研究了Nec-1-Exos,PARP1和AIFM1.1之间的相互作用.
主要成果:
- 通过心肌细胞成功内化Nec-1-Exos.
- 降低PARP1的监管和抑制AIFM1的核转移.
- 增加了ATP和超氧化物脱酶水平,减少了活性氧物种和malonaldehyde.
- 恢复了线粒体膜潜力和缓解了HF病理.
结论:
- 从iPSC衍生的外体有效地传递Nec-1,以准高频的PARP1/AIFM1轴.
- 这种方法显著减轻氧化应激和线粒体功能障碍在HF.
- 外体介导的NEC-1输送代表了心力衰竭管理的有前途的治疗策略.
相关概念视频
01:17The Extrinsic Apoptotic Pathway
6.3K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K